July, 2023

article thumbnail

The AI Revolution Has Arrived: Shaping the Next Generation of Pharma Marketing

PharmExec

Join five industry leaders as they unpack the transformative potential of artificial intelligence in the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.

Marketing 119
article thumbnail

Bernie Sanders proposes price caps on drugs developed with federal funds

Fierce Pharma

After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. | After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. Bernie Sanders, I-Vermont—a longtime opponent of Big Pharma—has become even more ubiquitous in his efforts to reduce drug prices.

Education 359
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Telehealth Visits Lead to Fewer Follow-Up Visits Than Office Visits

MedCity News

An Epic Research study found that 16 out of 24 specialties had higher follow-up rates within 90 days of an initial office visit than a telehealth visit. This includes mental health, physical medicine and rehabilitation and pain medicine, which all had a more than 20% higher follow-up rate after an in-person office appointment than a telehealth appointment.

Leads 120
article thumbnail

DigitalHealth.London’s Accelerator programme selects Aide

PharmaTimes

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Digital health tech: a solution to substance use disorders?

Pharmaceutical Technology

Substance use disorders leave people with long-term negative mental and physical health implications and can lead to death.

Leads 130
article thumbnail

Libraries, Publishers Together in Chicago

Copyright Clearance Center

According to PW’s Andrew Albanese, the ALA conference highlighted an organized response from the library and publishing communities to politicized attacks on the freedom to read.

98

More Trending

article thumbnail

Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech: report

Fierce Pharma

Caught in a litigation crossfire, Moderna has reportedly opened two new fronts in its COVID-19 vaccine patent war with Pfizer and BioNTech. | Moderna has lodged two new lawsuits at the High Court in Dublin, Ireland, and the Brussels Commercial Court in Belgium, Juve Patent first reported. This adds to a complex web of ongoing mRNA patent litigation.

352
352
article thumbnail

‘Hope Is Not a Business Model’: Digital Health Fundraising Advice from 2 VCs

MedCity News

Two VCs from Merck Global Health Innovation Fund recently offered fundraising advice for digital health companies. They told these firms to expect slower funding timelines, urged them not to be afraid of down or flat rounds, and advised them to spend time nailing down the specifics of their growth narrative.

120
120
article thumbnail

A New Era for Healthcare Delivery: The Impact of Telemedicine on the Concept of “Point-of-Care”

PM360

Today, the U.S. is facing an aging population, a mounting physician shortage, and increasing demands for a more equitable healthcare system. 1 According to the U.S. Surgeon General, burnout among healthcare workers has reached crisis levels. 2 It’s no wonder physicians across the country are limiting time with the industry and prioritizing their limited time with their patients.

article thumbnail

Eli Lilly’s retatrutide sets new record for weight loss in obesity space

Pharmaceutical Technology

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

119
119
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

The Powerful Potential of Improving User Experience in Open Scholarly Publishing

Copyright Clearance Center

Together, this panel reflected on successful collaborations that streamline OA processes, remove unnecessary work for the researchers, and enable cross-stakeholder transparency.

98
article thumbnail

Attracting Young Talent in Pharma

PharmExec

Rebekah Martin, senior VP of reward, inclusion, and talent acquisition at AstraZeneca, discusses ways to address the need for talent in pharma, how pharma can increase more interest in young talent, and how many roles in pharma will require a degree in the coming years in this Pharmaceutical Executive Podcast video.

Pharma 98
article thumbnail

Teva weighs sale of $2B API business as CEO Richard Francis embarks on 'Pivot to Growth' strategy: reports

Fierce Pharma

Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business | Teva is looking at strategic options for its active pharmaceutical ingredient unit, with a potential sale on the table, BNN Bloomberg and Benzinga have reported.

Sales 338
article thumbnail

Have Insurtechs Truly Disrupted the Mainstream Health Insurance Industry?

MedCity News

Insurtechs like Bright Health Group, Clover Health and Oscar Health set out to disrupt health insurance — but have they actually done so? Not in a positive way, several experts say.

Insurance 107
article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

How to Find the Best Digital Marketing Agency for Your Business 

Pharma Marketing Network

In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. However, with countless agencies available, it can be overwhelming to find the right one that aligns with your business objectives.

article thumbnail

Send in the Clones—Threads is Here and Likely to Stick Around

PM360

Digital fireworks were launched just hours after the July 4 th holiday in the U.S. with the official launch of Threads by Meta, a new platform that is a direct competitor of Twitter. It should be of no surprise to anyone that a flurry of Twitter competitors is now entering the marketplace. Ever since Elon Musk’s purchase of Twitter, a target has been on the back of one of the original and most polarizing social platforms.

Media 98
article thumbnail

Pharma Not the Only Ones Upset with PBM Practices

Pharmaceutical Commerce

The National Alliance of Healthcare Purchaser Coalitions releases resources for employers/health plan purchasers to offer insights on PBMs role in high prescription drug costs.

article thumbnail

CCC Announces Enhancement to Consortia Processing of Open Access Agreements In Its Innovative RightsLink for Scientific Communications Workflow Solution

Copyright Clearance Center

July 18, 2023 – Danvers, Mass. – CCC , the leading provider of Open Access (OA) workflow solutions, announces an enhancement to the processing of OA Agreements for university library consortia in its innovative scholarly communications workflow solution for the OA community, RightsLink for Scientific Communications (RLSC). Earlier this year, CCC engaged with members of the ESAC Initiative and administrators at university libraries representing nine global consortia across the U.S. and Europe to

Media 98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Novo Nordisk's GLP-1 drugs under review in Europe after reports flag possible suicide risks

Fierce Pharma

Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbust | Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbuster products.

Medicine 321
article thumbnail

Butterfly Network Launches AI Tool for Point-Of-Care Lung Ultrasounds

MedCity News

Butterfly Network recently launched an AI tool that can provide medical practitioners with an accurate B-line count from just a six-second lung ultrasound clip. By automatically counting B-lines in a lung image, the tool helps doctors quickly identify and assess a patient’s lung issues at the point of care.

article thumbnail

5 Strategies to Strengthen Relationships with HCPs

Pharma Marketing Network

Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceutical companies, and medical device manufacturers alike. These partnerships not only improve patient outcomes but also foster mutual trust and collaboration. In this blog, we will explore five effective strategies to enhance your relationship-building efforts with HCPs and ultimately achieve better healthcare outcomes.

Ethics 98
article thumbnail

The Second Order Effects of the Inflation Reduction Act: What Uncertainties Does Pharma Need to Plan For?

PM360

Since passage of the Inflation Reduction Act (IRA) in August 2022, the focus of many industry analysts and pharmaceutical companies has been on two important first order concerns: identifying products to be negotiated by the Centers for Medicare & Medicaid Services (CMS) and assessing the direct impact on prices. Most companies have now completed the critical analyses associated with these direct effects.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Harnessing AI for Pharma Sales

PharmExec

Artificial intelligence is steadily becoming a game changer for the pharma industry, particularly in commercialization activities, such as sales and marketing—and efforts to help highly sought treatments reach the right patients.

Sales 98
article thumbnail

The State of Scholarly Metadata in 2023: Industry Insights from Around the Globe

Copyright Clearance Center

After introducing The State of Scholarly Metadata: 2023 interactive report this April at the London Book Fair, we have continued to facilitate conversations about the importance of quality metadata with those in scholarly communications.

98
article thumbnail

Novo Nordisk brings new round of lawsuits against compounded versions of Ozempic and Wegovy

Fierce Pharma

As demand skyrockets for GLP-1 drugs that can trigger significant weight loss, unauthorized versions of the treatments have started to fill pharmacies. | In late May, the FDA warned of illegal knockoffs of Novo Nordisk’s Ozempic and Wegovy. And now, the Danish company has filed its second wave of lawsuits against pharmacies in the U.S. that are producing the copycats.

FDA 315
article thumbnail

A Startup Wins the First FDA Approval of a Cell Therapy for Type 1 Diabetes

MedCity News

CellTrans’s Lantidra is now the first FDA-approved cell therapy for type 1 diabetes. The therapy is made from islet cells sourced from deceased donors.

FDA 115
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s

article thumbnail

Less Is More—A Sharper Focus on Patient Needs Improves Adherence

PM360

“Drugs don’t work in patients who don’t take them,” C. Everett Koop, MD, U.S. Surgeon General, said in 1985. Novartis’ analysis of claims data from Nov. 2020 to Oct. 2021 revealed that roughly one in four prescriptions were never filled. 1 In addition, of patients who began therapy, more than 70% were no longer on their prescribed medication after 12 months. 1 Patients may discontinue if they cannot afford their out-of-pocket costs even with insurance coverage due to side effects or lack of perc

article thumbnail

Rationing strategies proliferate with cancer drugs in short supply

Pharmaceutical Technology

While drug shortages have been a major cause for concern over the past few years, medications to treat cancer are in particularly short supply.

Medical 111
article thumbnail

Crossing the Brain Barrier

PharmExec

COMPASS Pathways’ CEO, Kabir Nath, has a clear vision for psychedelics—and is leading the way with the company’s focus on psilocybin and efforts to separate the science from the hype.

Leads 98
article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.